Warning for South Africans using Yaz Plus birth control
South Africans are being urged to take immediate action following a recall of a specific batch of Yaz Plus birth control pills due to a serious packaging error.
Pharmaceutical company Bayer, in collaboration with the South African Health Products Authority (SAHPRA), announced the recall of batch WEW96J, which expires in March 2026.
The recall was prompted by a mix-up in the arrangement of hormone-containing and hormone-free tablets in some blister packs.
Instead of the standard configuration of 24 hormone tablets and four hormone-free tablets, certain packs contain 24 hormone-free tablets and only four hormone tablets.
This error renders the contraception ineffective and poses significant risks for users relying on the product for birth control.
Dr. Naren Jairam, Bayer’s medical director for pharmaceuticals, emphasised the seriousness of the issue, stating, “Bayer has initiated a Class II, Type A recall in line with SAHPRA’s guidelines to safeguard public health.
“A detailed public statement with additional information on the recall process will follow.”
SAHPRA has confirmed the recall and encouraged distributors and healthcare providers to act swiftly to ensure the defective packs are removed from circulation.
Pharmacies, wholesalers, and distributors have been advised to display recall notices prominently for at least one month and return all affected stock to Bayer.
Users of Yaz Plus are advised to check their packs immediately.
If the batch number WEW96J is found, they should stop using the pills and return them to the point of purchase for a replacement or refund.
Bayer has also set up a helpline for inquiries at 011 921 5000.
Healthcare professionals are urged to alert their patients and consult with anyone who may have been affected by the defective product.
Individuals who suspect they have been using the defective packs should contact their healthcare provider promptly for guidance.
This recall underscores the critical importance of quality control in pharmaceuticals and the responsibility of all stakeholders to prioritise patient safety.
Read: Massive warehouse busted for selling expired food, and the NPA crumbles
Loading ...